BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21182596)

  • 1. Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases.
    Kadomatsu T; Tabata M; Oike Y
    FEBS J; 2011 Feb; 278(4):559-64. PubMed ID: 21182596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of angiopoietin-like proteins in angiogenesis and metabolism.
    Hato T; Tabata M; Oike Y
    Trends Cardiovasc Med; 2008 Jan; 18(1):6-14. PubMed ID: 18206803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy.
    Oike Y; Akao M; Kubota Y; Suda T
    Trends Mol Med; 2005 Oct; 11(10):473-9. PubMed ID: 16154386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin-like proteins--potential therapeutic targets for metabolic syndrome and cardiovascular disease.
    Oike Y; Tabata M
    Circ J; 2009 Dec; 73(12):2192-7. PubMed ID: 19875897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietins and angiopoietin-like proteins in angiogenesis.
    Morisada T; Kubota Y; Urano T; Suda T; Oike Y
    Endothelium; 2006; 13(2):71-9. PubMed ID: 16728326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance.
    Tabata M; Kadomatsu T; Fukuhara S; Miyata K; Ito Y; Endo M; Urano T; Zhu HJ; Tsukano H; Tazume H; Kaikita K; Miyashita K; Iwawaki T; Shimabukuro M; Sakaguchi K; Ito T; Nakagata N; Yamada T; Katagiri H; Kasuga M; Ando Y; Ogawa H; Mochizuki N; Itoh H; Suda T; Oike Y
    Cell Metab; 2009 Sep; 10(3):178-88. PubMed ID: 19723494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of angiopoietin-like protein 1, 2, 3, 4, 5, and 7 genes during chick embryonic development.
    Niki D; Katsu K; Yokouchi Y
    Dev Growth Differ; 2009 Dec; 51(9):821-32. PubMed ID: 19951324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
    Miida T; Hirayama S
    Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of lipid metabolism via angiopoietin-like proteins.
    Kersten S
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1059-62. PubMed ID: 16246045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis.
    Oike Y; Yasunaga K; Suda T
    Int J Hematol; 2004 Jul; 80(1):21-8. PubMed ID: 15293564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-like proteins 3, 4 and 8: regulating lipid metabolism and providing new hope for metabolic syndrome.
    Li Y; Teng C
    J Drug Target; 2014 Sep; 22(8):679-87. PubMed ID: 24960069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-Like Proteins: Cardiovascular Biology and Therapeutic Targeting for the Prevention of Cardiovascular Diseases.
    Thorin E; Labbé P; Lambert M; Mury P; Dagher O; Miquel G; Thorin-Trescases N
    Can J Cardiol; 2023 Dec; 39(12):1736-1756. PubMed ID: 37295611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study.
    Legry V; Goumidi L; Huyvaert M; Cottel D; Ferrières J; Arveiler D; Bingham A; Wagner A; Ruidavets JB; Ducimetière P; Amouyel P; Meirhaeghe A
    Diabetes Metab; 2009 Sep; 35(4):287-92. PubMed ID: 19447061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like protein 3: development, analytical characterization, and clinical testing of a new ELISA.
    Stejskal D; Karpísek M; Humenanská V; Solichová P; Stejskal P
    Gen Physiol Biophys; 2007 Sep; 26(3):230-3. PubMed ID: 18063851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel human angiopoietin-like gene expressed mainly in heart.
    Zeng L; Dai J; Ying K; Zhao E; Jin W; Ye Y; Dai J; Xu J; Xie Y; Mao Y
    J Hum Genet; 2003; 48(3):159-62. PubMed ID: 12624729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative integromics on Angiopoietin family members.
    Katoh Y; Katoh M
    Int J Mol Med; 2006 Jun; 17(6):1145-9. PubMed ID: 16685428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering.
    Davis S; Papadopoulos N; Aldrich TH; Maisonpierre PC; Huang T; Kovac L; Xu A; Leidich R; Radziejewska E; Rafique A; Goldberg J; Jain V; Bailey K; Karow M; Fandl J; Samuelsson SJ; Ioffe E; Rudge JS; Daly TJ; Radziejewski C; Yancopoulos GD
    Nat Struct Biol; 2003 Jan; 10(1):38-44. PubMed ID: 12469114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family.
    Fu Z; Yao F; Abou-Samra AB; Zhang R
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1126-31. PubMed ID: 23261442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.